GSK Investigational Site

Rimini, Emilia-Romagna 47900

0 studies enrolling now · 7 studies all time

What they study most

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Bowel Dysfunction, Carcinoma of Breast, Constipation, HIV Infection, HIV-1 Infection, Herpes Zoster, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Infection, Human Immunodeficiency Virus, Infection, Human Immunodeficiency Virus I, Lung Cancer, Non-Small Cell

Studies at this site

• A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients — Stopped early
• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A — Completed
• Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication — Completed
• A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults — Stopped early
• Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer — Completed
• KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks — Completed